Skip to main content

Revolutionizing CRISPR Applications: High-Resolution sgRNA Analysis

Ensuring the quality of single guide RNA (sgRNA) is a major hurdle in CRISPR-Cas genome editing. Because these molecules are large (~100mer) and prone to complex secondary structures, separating them from nearly identical impurities requires precision.

Our latest application note demonstrates how the YMC Accura Triart Bio C18 column overcomes these challenges.

Key Breakthroughs in sgRNA Analysis:

►Exceptional Resolution: Successfully separates full-length sgRNA from closely related truncation impurities, such as n-1, n-2, and n-5 species.

►Bioinert Hardware: The specialized YMC Accura hardware minimizes non-specific adsorption to metal surfaces, ensuring high recovery and zero detectable carry-over.

►Widepore Efficiency: The 30 nm (300 Å) stationary phase is optimized for large oligonucleotides, providing superior mass transfer and peak shape.

►Sensitivity: Maintains consistent resolution and reliable performance even at low concentrations (down to 0.02 mg/mL).

Whether you are monitoring sequence fidelity or assessing the purity of modified sgRNA, this method provides a robust, reproducible solution for your CRISPR workflow.

Read the Application Note.

Posted on May 7, 2026.

Related Posts

April 23, 2026

Eliminating False Positives in PFOS Analysis: The Power of Methanol-Free Separation

Accurate determination of 𝗽𝗲𝗿𝗳𝗹𝘂𝗼𝗿𝗼𝗼𝗰𝘁𝗮𝗻𝗲𝘀𝘂𝗹𝗳𝗼𝗻𝗶𝗰 𝗮𝗰𝗶𝗱 (𝗣𝗙𝗢𝗦) in food samples is challenging due to bile acid–related compounds (e.g., taurocholic acid isomers). These species can produce the same SRM transition (m/z 499→80) as PFOS, leading to potential false positives without adequate chromatographic separation.

April 21, 2026

Using Volunteer Day to help Build Affordable Housing

We are incredibly proud to share how Victor Mansfield recently used his corporate Volunteer Day to make a life-changing difference in the Dominican Republic.

March 24, 2026

Revolutionizing Peptide Purification: A Blueprint for MCSGP Process Validation

The shift from batch to continuous manufacturing is a requirement in many biopharma applications, but regulatory compliance, specifically Process Validation, often remains a hurdle.

Designed and developed by